showed that PD1 − CD4+ T cells had higher TNFα and higher CCR4 expression, while their PD1+ CD4+ T cells had higher interferon-γ and lower CCR4 expression in non-responder cases to ICI in urothelial and renal cell carcinoma (52). This evidence concerns the gene RPL17 and hereditary clear cell renal cell carcinoma.